Stock Track | Novo Nordisk Soars 6.44% in Overnight Trading After FDA Action Against Rival's Wegovy Copy

Stock Track

Feb 09

Novo-Nordisk A/S (NVO) shares surged 6.44% in overnight trading, marking a significant 24-hour gain for the pharmaceutical giant.

The stock's jump came after the U.S. Food and Drug Administration indicated it would take action against rival Hims & Hers, which had planned to launch a $49 compounded version of Novo Nordisk's popular Wegovy weight-loss pill. Hims & Hers subsequently reversed course on the product launch, removing a potential competitive threat to Novo's flagship medication.

This regulatory development strengthens Novo Nordisk's position in the lucrative weight-loss drug market, where Wegovy has been a major commercial success. The FDA's intervention against compounded versions of the medication protects Novo's market exclusivity and revenue potential.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1169842535"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169842535\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169842535?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-09 09:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169842535","market":"hk","top_or_hot":-1,"title":"Stock Track | Novo Nordisk Soars 6.44% in Overnight Trading After FDA Action Against Rival's Wegovy Copy","media":"Stock Track","content":"<p>Novo-Nordisk A/S (NVO) shares surged 6.44% in overnight trading, marking a significant 24-hour gain for the pharmaceutical giant.</p><p>The stock's jump came after the U.S. Food and Drug Administration indicated it would take action against rival Hims & Hers, which had planned to launch a $49 compounded version of Novo Nordisk's popular Wegovy weight-loss pill. Hims & Hers subsequently reversed course on the product launch, removing a potential competitive threat to Novo's flagship medication.</p><p>This regulatory development strengthens Novo Nordisk's position in the lucrative weight-loss drug market, where Wegovy has been a major commercial success. The FDA's intervention against compounded versions of the medication protects Novo's market exclusivity and revenue potential.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Novo Nordisk Soars 6.44% in Overnight Trading After FDA Action Against Rival's Wegovy Copy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Novo Nordisk Soars 6.44% in Overnight Trading After FDA Action Against Rival's Wegovy Copy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-09 09:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novo-Nordisk A/S (NVO) shares surged 6.44% in overnight trading, marking a significant 24-hour gain for the pharmaceutical giant.</p><p>The stock's jump came after the U.S. Food and Drug Administration indicated it would take action against rival Hims & Hers, which had planned to launch a $49 compounded version of Novo Nordisk's popular Wegovy weight-loss pill. Hims & Hers subsequently reversed course on the product launch, removing a potential competitive threat to Novo's flagship medication.</p><p>This regulatory development strengthens Novo Nordisk's position in the lucrative weight-loss drug market, where Wegovy has been a major commercial success. The FDA's intervention against compounded versions of the medication protects Novo's market exclusivity and revenue potential.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"诺和诺德","start_time":0,"source_url":"","article_id":"1169842535","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169842535","pubTimestamp":1770601470,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Novo-Nordisk A/S (NVO) shares surged 6.44% in overnight trading, marking a significant 24-hour gain for the pharmaceutical giant.The stock's jump came after the U.S. Food and Drug Administration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德"},"translate_title":"个股追踪|FDA对竞争对手Wegovy副本采取行动后，诺和诺德隔夜交易飙升6.44%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1},"content_text":"Novo-Nordisk A/S (NVO) shares surged 6.44% in overnight trading, marking a significant 24-hour gain for the pharmaceutical giant.The stock's jump came after the U.S. Food and Drug Administration indicated it would take action against rival Hims & Hers, which had planned to launch a $49 compounded version of Novo Nordisk's popular Wegovy weight-loss pill. Hims & Hers subsequently reversed course on the product launch, removing a potential competitive threat to Novo's flagship medication.This regulatory development strengthens Novo Nordisk's position in the lucrative weight-loss drug market, where Wegovy has been a major commercial success. The FDA's intervention against compounded versions of the medication protects Novo's market exclusivity and revenue potential.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}